
SentiSense
Ctrl+K
Quick tip: Press
to search stocks
S
STE
Steris plc
$230.51
-8.00 (-3.35%)
Summary
Stories
News
Metrics
Fundamentals
Current Market Valuation
Current Price
$230.51
Live market price
P/E (TTM)
32.19
EPS: $7.16
P/S (TTM)
3.88
Price to Sales
TTM Quarters
4
Quarters included in TTM
Updated: 3/8/2026, 5:55:12 AM
Historical Trends
Range:
Revenue Over Time
Net Income Over Time
Short Interest (% of Float) Over Time
Short Interest
1.8M
% of Float
1.8%
Days to Cover
1.5
Avg Daily Vol
1.2M
Historical income statement data up to 5 years
Historical SEC Filings
Report Period
Debt/Equity
0.26
Leverage ratio
ROE (TTM)
9.92%
Return on equity
Income Statement
Revenue
$1.50B
Cost of Revenue
$840.70M
Gross Profit
$655.50M
Operating Income
$273.20M
Net Income
$194.30M
EPS (Quarter)
$1.96
EPS (TTM)
$7.16
Balance Sheet
Total Assets
$10.59B
Total Liabilities
$3.42B
Shareholders' Equity
$7.17B
Current Assets
$2.29B
Current Liabilities
$922.30M
Cash & Equivalents
--
Long-Term Debt
$1.90B
Cash Flow
Operating Cash Flow
$298.20M
Investing Cash Flow
$-98.50M
Financing Cash Flow
$-98.00M
Free Cash Flow
$199.70M
Profitability Margins
Gross Margin
43.81%
Operating Margin
18.26%
Net Profit Margin
12.99%
ROA (TTM)
6.71%
ROE (TTM)
9.92%
Data source: Polygon.io
Last updated: 3/8/2026, 5:55:13 AM
Company Profile
Symbol
STE
Market Cap
$22.61B
IPO Date
Jun 2, 1992
CEO
--
Employees
17,787
Sector
--
Industry
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Country
United States
Exchange
--
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
Read More